000 | 01275 a2200361 4500 | ||
---|---|---|---|
005 | 20250513032637.0 | ||
264 | 0 | _c19951023 | |
008 | 199510s 0 0 eng d | ||
022 | _a0033-3158 | ||
024 | 7 |
_a10.1007/BF02245945 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrivette, T H | |
245 | 0 | 0 |
_aKappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. _h[electronic resource] |
260 |
_bPsychopharmacology _cApr 1995 |
||
300 |
_a444-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnxiety _xchemically induced |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 | _aBenzeneacetamides |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Opioid, kappa _xagonists |
700 | 1 | _aTerrian, D M | |
773 | 0 |
_tPsychopharmacology _gvol. 118 _gno. 4 _gp. 444-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02245945 _zAvailable from publisher's website |
999 |
_c7568087 _d7568087 |